Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, August 03, 2016

Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan



Open access

In conclusion, Strategy 1 (IHC test followed by BRAF test) evaluated in our study has been found to be cost-effective relative to the Referent strategy. This is the first cost-effectiveness analysis for evaluating different genetic testing strategies for LS in Taiwan. As such, the results will be informative for the NHI when considering offering screening for LS in patients newly diagnosed with CRC.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.